Masahisa Murakami
Directeur/Membre du Conseil chez Biomedica Solution KK
Postes actifs de Masahisa Murakami
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biomedica Solution KK
 Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Directeur/Membre du Conseil | 01/06/2015 | - |
Historique de carrière de Masahisa Murakami
Anciens postes connus de Masahisa Murakami
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TELLA, INC. | Directeur/Membre du Conseil | 01/04/2010 | - |
| Compliance Officer | 01/04/2010 | - |
Statistiques
Internationale
| Japon | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Compliance Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Biomedica Solution KK
Biomedica Solution KK BiotechnologyHealth Technology Part of Tella, Inc., Biomedica Solution KK is a Japanese company that manufactures cell production facilities. | Health Technology |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Bourse
- Insiders
- Masahisa Murakami
- Expérience
